Home

Melissa M. Tomkiel

CIK 1859484 · Co-CEO and General Counsel · last filed 2026-09-10

Melissa M. Tomkiel is a Co-CEO and General Counsel who has filed 62 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing shows the insider had shares withheld for taxes covering $157.9K of SRTA on Sep 10, 2026. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.79M

Companies

3

Total Filings

62

Lifetime Open-Market Net

-$2.54M

Filer Profile

Reported Address
C/O BLADE AIR MOBILITY, INC.
31 HUDSON YARDS, 14TH FLOOR
NEW YORK, NY 10001
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRTA Co-CEO and General Counsel 2,066,617 $5.22 $10.79M -$174.5K 4 2026-09-10
Strata Critical Medical, Inc. (SRTAW) Delisted Co-CEO and General Counsel 2,244,254 $0.00 $1.3K $0 9 2026-04-27
Strata Critical Medical, Inc. (BLDEW) Delisted President and General Counsel 1,169,334 $0.18 $209.8K -$2.37M 39 2025-08-07

Recent Filings

62 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-10 SRTA Tax (F) −29,730 -$157.9K EDGAR
2026-08-03 SRTA Mixed +203,573 -$1.08M EDGAR
2026-06-18 SRTA Tax (F) −29,730 -$174.5K EDGAR
2026-06-10 SRTA Sell (S) −29,730 -$174.5K EDGAR
2026-04-27 Strata Critical Medical, Inc. (SRTAW) Delisted Mixed +308,514 -$1.58M EDGAR
2026-03-10 Strata Critical Medical, Inc. (SRTAW) Delisted Tax (F) −29,372 -$133.3K EDGAR
2026-01-05 Strata Critical Medical, Inc. (SRTAW) Delisted Exer (M) +276,960 $49.9K EDGAR
2025-12-12 Strata Critical Medical, Inc. (SRTAW) Delisted Tax (F) −34,018 -$149.0K EDGAR
2025-11-12 Strata Critical Medical, Inc. (SRTAW) Delisted Exer (M) +27,778 $5.0K EDGAR
2025-11-05 Strata Critical Medical, Inc. (SRTAW) Delisted Mixed +102,270 -$536.5K EDGAR
Showing 1–10 of 62
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.